Pericarditis
A patient guide to pericarditis symptoms, diagnostic criteria, treatment, exercise restriction and recurrence prevention.
Pericarditis is inflammation of the membrane surrounding the heart. Chest pain is often sharp, worse with deep breathing or lying flat and relieved by sitting forward, although symptoms vary. An ECG change, pericardial rub or new effusion may support the diagnosis.
Assessment
Evaluation includes clinical examination, ECG, inflammatory markers and echocardiography. Cardiac MRI or other testing may be needed when the diagnosis is uncertain, myocarditis is suspected or the course is atypical. Fever, a large effusion, tamponade, trauma, immunosuppression or failure to improve indicate higher risk and may require hospital assessment.
Treatment and Recovery
Anti-inflammatory treatment and colchicine are commonly used when appropriate, with dose and duration adapted to the patient. Physical exertion is reduced until symptoms, inflammation and relevant cardiac findings have resolved. Treatment is tapered only after a stable response because abrupt reduction can contribute to recurrence.
Urgent assessment is needed for fainting, low blood pressure, worsening breathlessness or evidence of a rapidly increasing effusion.
Clinical Depth and Risk Assessment
Risk is not defined by the diagnostic label alone. Symptoms, ECG and rhythm findings, ventricular function, myocardial scar or structural change, family history, associated disease and previous events are integrated. Genetic results, when relevant, require expert interpretation; a variant of uncertain significance is not equivalent to a diagnosis.
Diagnostic Strategy and Limitations
Testing is selected to answer a specific question. ECG, ambulatory monitoring, echocardiography, cardiac MRI, CT, laboratory testing, exercise assessment or invasive evaluation have complementary roles. A normal test may not exclude an intermittent disorder, while an abnormal measurement must be checked against technical quality and clinical probability.
Treatment Decision Framework
Treatment may combine risk-factor control, condition-specific medicines, rhythm or heart-failure therapy, catheter procedures, surgery and implanted devices. These options address different mechanisms and are not automatically substitutes for one another. Expected benefit, uncertainty, procedural burden and the patient’s informed preferences should be discussed explicitly.
Long-Term Follow-up
Follow-up assesses symptoms, exercise capacity, rhythm burden, ventricular function and treatment tolerance over time. Family screening may be appropriate in inherited or suspected inherited disease. New fainting, sustained rapid rhythm, chest pain, neurological symptoms or rapidly worsening breathlessness requires urgent assessment.
Questions to Discuss With the Cardiology Team
- Which finding has the greatest influence on my present risk?
- Which test or treatment would genuinely change management?
- What symptoms should lead to an earlier appointment or emergency care?
- Do relatives need clinical or genetic assessment?
Medical Information Note
This page supports an informed discussion with the clinical team. It does not provide a personal diagnosis, medicine dose or sports-clearance decision.